Implantable Device for Injection-free Diabetes Control

Implantable Device for Injection-free Diabetes Control

Scientists at the Massachusetts Institute of Technology (MIT) have pioneered an innovative device that could revolutionize the treatment of Type 1 diabetes. This implantable mechanism holds insulin-producing islet cells, alongside a miniature oxygen-generating component, negating the need for regular insulin injections. The ingenuity lies in the device's capability to produce oxygen by separating body water vapor, ensuring the enclosed cells remain viable and continuously produce insulin.

Staff Thu, 10/12/2023 - 17:25

[original story: Circuit Digest]

Circuit Digest 12 Oct 12:55